Molecular action of anti-mycobacterial agents

Tubercle and Lung Disease

Volumn 78, Issue 2, 1998, Pages 89-98

  Chopra, I ^a   Brennan, P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; ANTIMYCOBACTERIAL AGENT; CAPREOMYCIN; CLOFAZIMINE; CYCLOSERINE; DAPSONE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; MACROLIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMYCIN DERIVATIVE; STREPTOMYCIN; THIOACETAZONE; TIOCARLIDE;

ANTIBACTERIAL ACTIVITY; DRUG MECHANISM; MYCOBACTERIOSIS; PRIORITY JOURNAL; REVIEW;

EID: 0031409343     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8479(98)80001-4     Document Type: Review

References (81)

1. Brennan PJ Nikaido H The envelope of mycobacteria Annu Rev Biochem 64 1995 29 63
2. Greenwood D Historical introduction O'Grady F Lambert HP Finch RG Greenwood D Antibiotic and Chemotherapy 7th Ed. 1997 Churchill Livingstone Edinburgh 2 9
3. Davidson PT Le HQ Drug treatment of tuberculosis — 1992 Drugs 43 1992 651 673
4. Tillotson GS Tuberculosis — new aspects of chemotherapy J Med Microbiol 44 1996 16 20
5. Grange J Antimycobacterial agents O'Grady F Lambert HP Finch RG Greenwood D Antibiotic and Chemotherapy 7th Ed. 1997 Churchill Livingstone Edinburgh 449 512
6. Watt B In-vitro sensitivities and treatment of less common mycobacteria J Antimicrob Chemother 39 1997 567 574
7. O'Grady F Cycloserine, amino acid analogues and oligopeptides O'Grady F Lambert HP Finch RG Greenwood D Antibiotic and Chemotherapy 7th Ed. 1997 Churchill Livingstone Edinburgh 344 345
8. Otten H Experimental evaluation of efficacy. VIII Cycloserine (CS) and terizidone (TZ) Bartmann K Antituberculosis drugs Handbook of Experimental Pharmacology Volume 84 1988 Springer-Verlag Berlin 158 166
9. Gale EF Cundliffe E Reynolds PE Richmond MH Waring MJ The molecular basis of antibiotic action 2nd Ed. 1981 John Wiley and Sons London
10. Russell AD Chopra I Understanding antibacterial action and resistance 2nd Ed. 1996 Ellis Horwood London
11. David HL Goldman DS Takayama K Inhibition of the synthesis of wax d peptidoglycolipid of Mycobacterium tuberculosis by d -cycloserine Infect Immun 1 1970 74 77
12. David HL Takayama K Goldman DS Susceptibility of mycobacterial d -alanyl- d -alanine synthetase to d -cycloserine Am Rev Respir Dis 100 1969 579 581
13. Takayama K David HL Wang L Goldman DS Isolation and characterization of uridine diphosphate-N-glycolylmuramyl- l -alanyl-γ- d -glutamyl-meso-α,α′-diaminopimelic acid from Mycobacterium tuberculosis Biochem Biophys Res Comm 39 1970 7 12
14. Petit J-F Adam A Wietzerbin-Falszpan J Isolation of UDP-N-glycolylmuramyl-(Ala, Glu, DAP) from Mycobacterium phlei FEBS Lett 6 1970 55 57
15. Cáceres NE Harris NB Wellehan JF Feng Z Kapur V Barletta RG Overexpression of the d -alanine racemase gene confers resistance to d -cycloserine in Mycobacterium smegmatis J Bacteriol 179 1997 5046 5055
16. Brown EM Reeves DS Quinolones O'Grady F Lambert HP Finch RG Greenwood D Antibiotic and Chemotherapy 7th Ed. 1997 Churchill Livingstone Edinburgh 419 452
17. Renau TE Gage JW Dever JA Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position Antimicrob Agents Chemother 40 1996 2363 2368
18. Pan X-S Ambler J Mehtar S Fisher ML Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae Antimicrob Agents Chemother 40 1996 2321 2326
19. Blanchard JS Molecular mechanisms of drug resistance in Mycobacterium tuberculosis Annu Rev Biochem 65 1996 215 239
20. Williams KJ Chan R Piddock LVJ gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong Kong J Antimicrob Chemother 37 1996 1032 1034
21. Kirst HA Sides GD New directions for macrolide antibiotics: structural modifications and in vitro activity Antimicrob Agents Chemother 33 1989 1413 1418
22. Bryskier A Butzler JP Macrolides O'Grady F Lambert HP Finch RG Greenwood D Antibiotic and Chemotherapy 7th Ed. 1997 Churchill Livingstone Edinburgh 377 393
23. Casal M Guitierrez J Gonzalez J Ruiz P In vitro susceptibility of Mycobacterium tuberculosis to a new macrolide antibiotic R 28965 Tubercle 68 1987 141 143
24. Brown BA Wallace RJ Onyi GO de Rosas V Wallace RJ Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae , and M. chelonae -like organisms Antimicrob Agents Chemother 36 1992 180 184
25. Rastogi N Goh KS Bryskier A In vitro activity of roxithromycin against 16 species of atypical mycobacteria and effect of pH on its radiometric MICs Antimicrob Agents Chemother 37 1993 1560 1562
26. Heifets LB Clarithromycin against Mycobacterium avium complex infections Tuber Lung Dis 77 1996 19 26
27. Meier A Kirschner P Springer B Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare Antimicrob Agents Chemother 38 1994 381 384
28. Bottger EC Resistance to drugs targeting protein synthesis in mycobacteria Trends Microbiol 2 1994 416 421
29. Parenti F Lancini G Rifamycins O'Grady F Lambert HP Finch RG Greenwood D Antibiotic and Chemotherapy 7th Ed. 1997 Churchill Livingstone Edinburgh 453 459
30. Grange JM Detection of drug resistance in Mycobacterium leprae and the design of treatment regimens for leprosy Heifets LB Drug Susceptibility in the Chemotherapy of Mycobacterial Infections 1991 CRC Press Boca Raton, Florida 161 177
31. Elliot AM Lambert HP Mycobacterial infections O'Grady F Lambert HP Finch RG Greenwood D Antibiotic and Chemotherapy 7th Ed. 1997 Churchill Livingstone Edinburgh 831 853
32. Saito H Tomioka H Sato K In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins Antimicrob Agents Chemother 35 1991 542 547
33. Luna-Herrera J Reddy MV Gangadharam PRJ In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli Antimicrob Agents Chemother 39 1995 440 444
34. Levin ME Hatfull GF Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance Mol Microbiol 8 1993 277 285
35. Cole ST Mycobacterium tuberculosis : drug-resistance mechanisms Trends Microbiol 2 1994 411 415
36. Winder FG Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria Ratledge C Stanford J The Biology of the Mycobacteria. Volume 1, Physiology, Identification and Classification 1982 Academic Press London 353 438
37. Bodmer T Zurcher G Imboden P Telenti A Mutation position and type of substitution in the β-subunit of the RNA polymerase influence in vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis J Antimicrob Chemother 35 1995 345 348
38. Jin DJ Gross CA Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampin resistance J Mol Biol 202 1988 45 58
39. Phillips I Shannon KP Aminoglycosides and aminocyclitols O'Grady F Lambert HP Finch RG Greenwood D Antibiotic and Chemotherapy 7th Ed. 1997 Churchill Livingstone Edinburgh 164 201
40. Trnka L Mison P Experimental evaluation of efficacy II. Streptomycin (SM) — Dihydrostreptomycin (DHSM) Bartmann K Antituberculosis drugs Handbook of Experimental Pharmacology Volume 84 1988 Springer-Verlag Berlin 68 91
41. Sutton WB Gordee RS Wick WE Stanfield L In vitro and in vivo laboratory studies on the antituberculosis activity of capreomycin Ann New York Acad Sci 135 1966 947 959
42. Otten H Experimental evaluation of efficacy XII. Capreomycin (CM) Bartmann K Antituberculosis drugs Handbook of Experimental Pharmacology Volume 84 1988 Springer-Verlag Berlin 191 197
43. Ji B Grosset JH Recent advances in the chemotherapy of leprosy Lepr Rev 61 1990 313 329
44. Ausina V Condom MJ Mirelis B Luqin M Coll P Prats G In vitro activity of clofazimine against rapidly growing non chromogenic mycobacteria Antimicrob Agents Chemother 29 1986 951 952
45. Lindholm-Levy PJ Heifets LB Clofazimine and other rimino-compounds: minimal inhibitory and minimal bactericidal concentrations at different pHs for Mycobacterium avium complex Tubercle 69 1988 179 186
46. Jagannath C Reddy MV Kailasam S O'Sullivan JF Gangadharam PRJ Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis Am J Respir Crit Care Med 151 1995 1083 1086
47. Kulkari VM Seydel JK Inhibitory activity and mode of action of action of diaminodiphenylsulphone in cell-free folate synthesizing systems prepared from Mycobacterium lufu and Mycobacterium leprae Chemotherapy 29 1983 58 67
48. Steel WF Williams DL Dallas WS Gillis TP The folP of Mycobacterium leprae and dapsone resistance Thirty-Second US-Japan Cooperative Medical Science Program, Tuberculosis-Leprosy Research Conference Cleveland, Ohio 1997 63 67
49. Khoo K-H Douglas E Azadi P Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis J Biol Chem 271 1996 28682 28690
50. Takayama K Kilburn JO Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis Antimicrob Agents Chemother 33 1989 1493 1499
51. Mikušová K Slayden RA Besra GS Brennan PJ Biogenesis of the mycobacterial cell wall and the site of action of ethambutol Antimicrob Agents Chemother 39 1995 2484 2489
52. Belanger AE Besra GS Ford ME The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol Proc Natl Acad Sci USA 93 1996 11919 11924
53. Lee RE Mikušová K Brennan PJ Besra GS Synthesis of the mycobacterial arabinose donor β- d -arabinofuranosyl-1-monophosphoryldecaprenol, development of a basic arabinosyl-transferase assay and identification of ethambutol as an arabinosyl transferase inhibitor J Am Chem Soc 117 1995 11829 11832
54. Telenti A Philipp WJ Sreevatsan S The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol Nature Med 3 1997 567 570
55. Zhang Y Heym B Allen B Young D Cole S The catalase-peroxidase gene and isoniazid resistance in Mycobacterium tuberculosis Nature (London) 358 1992 591 593
56. Zhang Y Garbe T Young D Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations Mol Microbiol 8 1993 521 524
57. Heym B Zhang Y Poulet S Young D Cole ST Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis J Bacteriol 175 1993 4255 4259
58. Heym B Alzari PM Honore N Cole ST Missense mutations in the catalase-peroxidase gene, katG , are associated with isoniazid resistance in Mycobacterium tuberculosis Mol Microbiol 15 1995 235 245
59. Morris S Bai GH Suffys P Portillo-Gomez L Fairchock M Rouse D Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis J Infect Dis 171 1995 954 960
60. Johnsson K Schultz PG Mechanistic studies of the oxidation of INH by the catalase peroxidase from Mycobacterium tuberculosis J Am Chem Soc 116 1994 7425 7426
61. Winder FG Collins PB Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis J Gen Microbiol 63 1970 41 48
62. Takayama K Schnoes HK Armstrong EL Boyle RW Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis J Lipid Res 16 1975 308 317
63. Takayama K Davidson LA Isonicotinic acid hydrazide Hahn FE Antibiotics VI Mechanism of action of Antibacterial Agents 1979 Springer Verlag Berlin 98 119
64. Mdluli K Zhu Y Crane DC Barry CE III The molecular target of activated isoniazid in Mycobacterium tuberculosis Thirty-First Research Conference on Tuberculosis and Leprosy, US-Japan Cooperative Medical Science Program Nagasaki, Japan 1996 30 34
65. Banerjee A Dubnau E Quemard A inhA , a gene encoding a target for INH and ethionamide in Mycobacterium tuberculosis Science 263 1994 227 230
66. Quemard A Sacchettini JC Dessen A Enzymatic characterization of the target for INH in Mycobacterium tuberculosis Biochemistry 34 1995 8235 8241
67. Dessen A Quemard A Blanchard JS Jacobs WR Jr Sacchettini JC Crystal structure and function of the INH target of Mycobacterium tuberculosis Science 267 1995 1638 1641
68. Youmans GP Youmans AS Doub L The effect of thiocarbanidin and related compounds on Mycobacterium tuberculosis var. hominis in vitro and in vivo Am Rev Tuberc 77 1958 301 310
69. Winder FG Collins PB Whelan D Effects of ethionamide and isoxyl on mycolic acid synthesis in Mycobacterium tuberculosis BCG J Gen Microbiol 66 1971 379 380
70. Offe HA Historical introduction and chemical characteristics of antituberculosis drugs Bartmann K Antituberculosis drugs Handbook of Experimental Pharmacology Volume 84 1988 Springer-Verlag Berlin 1 30
71. Trnka L Mison P Drugs and treatment regimens. 1. p-aminosalicylic acid (PAS) Bartmann K Antituberculosis Drugs Handbook of Experimental Pharmacology Volume 84 1988 Springer-Verlag Berlin 51 68
72. McCune RM Feldman FM McDermott W Microbial persistence II. Characteristics of the sterile state of tubercle bacilli J Exp Med 123 1966 468 486
73. Grosset JH Present status of chemotherapy for tuberculosis Rev Infect Dis 11 Suppl 2 1989 S347 S352
74. Konno K Feldman FM McDermott W Pyrazinamide susceptibility and amidase activity of tubercle bacilli Am Rev Respir Dis 95 1967 461 469
75. McDermott W Tompsett R Activation of pyrazinamide and nicotinamide in acidic environments in vitro American Review of Tuberculosis 70 1954 748 754
76. Cynamon MH Klemens SP Antimycobacterial activity of a series of pyrazinoic acid esters J Med Chem 35 1982 1212 1215
77. Brender E A simple way of detecting pyrazinamide resistance Tubercle 53 1972 128 131
78. Crowle AJ Dahl R Ross E May MH Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic Infect Immun 59 1991 1823 1831
79. Scorpio A Zhang Y Mutations in pncA , a gene encoding pyrazinamidase/nicotinamidase, cause resistance to antituberculous drug pyrazinamide in tubercle bacillus Nature Medicine 2 1996 1 6
80. Trnka L Experimental evaluation of efficacy III. Thiosemicarbazones (TSC) Bartmann K Antituberculosis Drugs Handbook of Experimental Pharmacology Volume 84 1988 Springer-Verlag Berlin 92 103
81. Heifets LB Lindholm-Levy PJ Flory M Thiacetazone: in vitro activity against Mycobacterium avium and M. tuberculosis Tubercle 71 1990 287 291